featured-image

utah778/iStock via Getty Images Nordson ( NASDAQ: NDSN ) said it will acquire Atrion ( ATRI ) for $460 per share in cash, which represents a total transaction enterprise value of ~$800 million. Shares of ATRI rose 4% in pre-market trade, while NDSN was largely flat. The deal is expected to expand Nordson’s medical portfolio into new markets and therapies.

The transaction is expected to close prior to Nordson’s fiscal year-end 2024. Atrion is a manufacturer of proprietary medical products. More on Nordson Nordson: Premium Player Delivering A Soft Performance Nordson Corporation: Performing Well And Fairly Valued Nordson Non-GAAP EPS of $2.



34 beats by $0.02, revenue of $651M misses by $14.08M.

Back to Health Page